Evaluation of trained immunity induction by dpB in human monocytes
Conference in EOHA 2026 Annual Scientific Meeting. International One Health Congress
May 18th, 2026
Sánchez-Morales L., Garcia-Seco T., Vuscan P., Dominguez L., Netea M. and Perez-Sancho M.
Trained immunity refers to the long-term functional reprogramming of innate immune cells, leading to enhanced responses upon secondary stimulation. DpB is a BCG porcine-derived immunomodulator that has shown protective and immunomodulatory effects in animal models of SARS-CoV-2, Streptococcus suis and Salmonella spp. However, its capacity to induce trained immunity in human innate immune cells has not been investigated yet. Given the growing interest in trained immunity-based strategies, evaluating the effects of dpB in human monocytes may support the development of innovative complementary prophylactic tools within One Health
![]() | Servicio de Identificación y Caracterización Microbiana (ICM). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM). |
![]() | Departamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM). |
| Radboud University Nijmegen Medical Cente (UMCN). | |
| University of Bonn Medical Centre. | |
Link to EOHA 2026 Annual Scientific Meeting. International One Health Congress

